产品说明
一般描述
Certified pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to pharmacopeia primary standards
Vecuronium Bromide is a nondepolarizing neuromuscular blocking agent, which helps for adequate muscle relaxation for all types of surgical procedures in the absence of cardiorespiratory depressant effects of deep anesthesia.
应用
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
Vecuronium Bromide may be used as a pharmaceutical reference standard for the quantification of the analyte in pharmaceutical formulations using high-performance liquid chromatography and capillary zone elctrophoresis techniques.
分析说明
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
其他说明
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
附注
To see an example of a Certificate of Analysis for this material enter LRAA5296 in the slot below. This is an example certificate only and may not be the lot that you receive.
基本信息
经验(实验)分子式 | C34H57BrN2O4 |
分子量 | 637.73 |
Beilstein | 4837308 |
EC 号 | 256-723-9 |
MDL编号 | MFCD00867762 |
PubChem化学物质编号 | 329823518 |
产品性质
质量水平 | 300 |
等级 | certified reference material pharmaceutical secondary standard |
CofA | current certificate can be downloaded |
包装 | pkg of 100 mg |
technique(s) | HPLC: suitable gas chromatography (GC): suitable |
application(s) | pharmaceutical (small molecule) |
格式 | neat |
药典可追溯性 | traceable to PhEur Y0000561 traceable to USP 1711155 |
储存温度 | 2-8℃ |
SMILES string | [Br-].CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@@H]([C@@H]4OC(C)=O)[N+]5(C)CCCCC5)[C@@]2(C)C[C@@H]1N6CCCCC6 |
InChI | 1S/C34H57N2O4.BrH/c1-23(37)39-31-20-25-12-13-26-27(34(25,4)22-29(31)35-16-8-6-9-17-35)14-15-33(3)28(26)21-30(32(33)40-24(2)38)36(5)18-10-7-11-19-36;/h25-32H,6-22H2,1-5H3;1H/q+1;/p-1/t25-,26+,27-,28-,29-,30-,31-,32-,33-,34-;/m0./s1 |
InChI key | VEPSYABRBFXYIB-PWXDFCLTSA-M |
Gene Information | human ... CHRNA1(1134), CHRNB1(1140), CHRND(1144), CHRNE(1145), CHRNG(1146) |
安全信息
象形图 | |
警示用语: | Warning |
危险声明 | H302 |
危险分类 | Acute Tox. 4 Oral |
储存分类代码 | 13 - Non Combustible Solids |
WGK | WGK 3 |
闪点(F) | Not applicable |
闪点(C) | Not applicable |
SUPELCO